Baxter International | Srodki Pieniężne I Ekwiwalent



Cash And Equivalent Zmiana Data
Abbott USD 6.53B 1.08B 2025-03
AtriCure USD 99.88M 22.84M 2025-03
Avanos Medical USD 107.7M 18.7M 2024-12
Baxter International USD 1.76B 344M 2024-12
Becton, Dickinson and Co. USD 711M 1.01B 2024-12
Boston Scientific USD 414M 2.09B 2024-12
Cooper Companies USD 100.9M 6.7M 2025-01
Dexcom USD 606.1M 15.1M 2024-12
Edwards Lifesciences USD 3.05B 631.2M 2024-12
Fresenius EUR 2.28B 788M 2024-12
Globus Medical USD 784.44M 161.67M 2024-12
Halozyme Therapeutics USD 115.85M 38.47M 2024-12
ICU Medical USD 308.57M 3.95M 2024-12
Insulet USD 820M 133.5M 2024-12
Integra LifeSciences USD 246.38M 31.22M 2024-12
Intuitive Surgical USD 9.1B 268.8M 2025-03
J&J USD 38.47B 32.35B 2025-03
Laboratory Of America USD 369.4M 1.15B 2025-03
Masimo USD 177.6M 19.1M 2024-12
Medtronic USD 1.24B 154M 2025-01
Merit Medical Systems USD 395.53M 18.81M 2025-03
Quest Diagnostics USD 188M 361M 2025-03
Smith & Nephew 568M 266M 2024-06
Stryker USD 3.65B 198M 2024-12
Tandem Diabetes Care USD 53.57M 15.66M 2025-03
Teleflex USD 284.12M 6.07M 2025-03
Terumo JPY 212.56B 17.64B 2024-12
Zimmer Biomet Holdings USD 525.5M 43.5M 2024-12



Baxter International Srodki Pieniężne I Ekwiwalent - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - May 2025.